- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03998475
Transition Preparation Intervention for Young Adults With Type 1 Diabetes
5 november 2020 uppdaterad av: Virginia Commonwealth University
Implementing a Transition Preparation Intervention for Young Adults With Type 1 Diabetes in an Integrated Healthcare Setting
The purpose of this research study is to find out more about how to support young adults (ages 18-22) with type 1 diabetes as they prepare to transition from pediatric and adult endocrinology medical care.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Detaljerad beskrivning
The overarching goal of the proposed trial is to improve diabetes self-management and glycemic control in young adults and prepare them for the transition to adult endocrinology.
The current application will investigate the impact of a multisystem transition preparation intervention for young adults (ages 18-22) with T1D.
Twenty-five young adults and a parent will be enrolled in a 6-month transition preparation program which will use a hybrid in-person and technology delivery structure.
Providers will receive training highlighting their role preparing young adults for transition and provides practical tips to use in their communication with young adults.
If effective, this multisystem intervention, designed to enhance T1D self-management and increase young adults' readiness for transition to adult healthcare during this critical developmental period, has the potential to inform clinical practice guidelines.
Studietyp
Interventionell
Inskrivning (Faktisk)
62
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Virginia
-
Richmond, Virginia, Förenta staterna, 23298
- Children's Hospital of Richmond at Virginia Commonwealth University
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
Both members of the youth/parent dyad must meet all eligibility criteria
Young adults
- English-speaking
- patients in Pediatric Endocrinology at Children's Hospital of Richmond (CHoR) at Virginia Commonwealth University (VCU)
- between ages 18-22 yrs with a
- diagnosis of T1D for >1 year
Parents
- greater than 18 years of age
- provide care to the young adult with T1D
- are willing to participate in the intervention
Medical providers
• provide care to patients with T1D ages 18-22 yrs in Pediatric Endocrinology at CHoR
Exclusion Criteria:
Young adults
- significant psychiatric, cognitive, medical or developmental conditions that would impair their ability to complete assessments and/or engage in diabetes self-care behaviors (e.g., malignancies, psychosis, intellectual disability), as documented in the medical record or revealed during eligibility screening, or
- medically-induced diabetes or diagnosis of diabetes other than type 1 diabetes
Parents
- non-English speaking
- psychiatric, cognitive, or developmental conditions that would impair their ability to complete assessments and/or engage in the intervention as determined at study screening
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: Transition preparation program
Transition preparation intervention for young adults with type 1 diabetes (T1D)
|
Young adult participants and parents will complete transition preparation sessions that include meeting with a health behavior coach for in-person sessions and review of materials sent electronically between study visits.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Number of sessions attended
Tidsram: 6 months
|
Number of study visits (attendance)
|
6 months
|
Number of session views
Tidsram: 6 months
|
Number of opened electronic materials (e.g., opened messages in the patient health portal))
|
6 months
|
Program acceptability - young adult
Tidsram: 9 months
|
Young adult report on satisfaction with the program via an exit survey
|
9 months
|
Program acceptability - parent
Tidsram: 9 months
|
Parent report on satisfaction with the program via an exit survey
|
9 months
|
Program acceptability - provider
Tidsram: 9 months
|
Provider report on satisfaction with the program via an exit survey
|
9 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Change in Glycemic control
Tidsram: Baseline to 9 months
|
Measurement of hemoglobin A1c (A1c; reported as a percentage)
|
Baseline to 9 months
|
Diabetes-related hospitalizations
Tidsram: 9 months
|
Participant report and medical record review of count of reported diabetes-related hospitalizations and complications
|
9 months
|
Change in adherence to diabetes care regimen
Tidsram: Baseline to 9 months
|
Average of young adult and parent participant reports on the Diabetes Management Questionnaire (DMQ)
|
Baseline to 9 months
|
Change in transition readiness
Tidsram: Baseline to 9 months
|
Average of young adult and parent participant reports on the Transition Readiness Assessment Questionnaire (TRAQ)
|
Baseline to 9 months
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Change in diabetes self-efficacy
Tidsram: Baseline to 9 months
|
Participant (young adult) report on the Self-Efficacy for Diabetes Self-Management (SEDSM)
|
Baseline to 9 months
|
Change in diabetes quality of life
Tidsram: Baseline to 9 months
|
Participant (young adult) report on the Pediatric Quality of Life Diabetes Module
|
Baseline to 9 months
|
Change in diabetes family responsibility
Tidsram: Baseline to 9 months
|
Average of young adult and parent participant reports on the Diabetes Family Responsibility Questionnaire (DFRQ)
|
Baseline to 9 months
|
Change in diabetes family conflict
Tidsram: Baseline to 9 months
|
Average of young adult and parent participant reports on the Diabetes Family Conflict Scale (DFCS)
|
Baseline to 9 months
|
Change in depression
Tidsram: Baseline to 9 months
|
Participant (young adult) report on the Center for Epidemiologic Studies Depression Scale (CESD)
|
Baseline to 9 months
|
Change in young adult diabetes distress
Tidsram: Baseline to 9 months
|
Participant (young adult) report on the Diabetes Distress Scale
|
Baseline to 9 months
|
Change in parent diabetes distress
Tidsram: Baseline to 9 months
|
Participant (parent) report on the Diabetes Distress Scale for Parents of Teens with T1D
|
Baseline to 9 months
|
Change in autonomy support
Tidsram: Baseline to 9 months
|
Participant (young adult) report on the autonomy support sub-scale of the Barriers to Diabetes Adherence Questionnaire
|
Baseline to 9 months
|
Change in problem solving
Tidsram: Baseline to 9 months
|
Participant (young adult) report on the Diabetes Adherence Problem Solving Questionnaire
|
Baseline to 9 months
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Laura Caccavale, PhD, Virginia Commonwealth University
- Huvudutredare: Melanie Melanie, PhD, Virginia Commonwealth University
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
11 juli 2019
Primärt slutförande (Faktisk)
16 september 2020
Avslutad studie (Faktisk)
16 september 2020
Studieregistreringsdatum
Först inskickad
24 juni 2019
Först inskickad som uppfyllde QC-kriterierna
24 juni 2019
Första postat (Faktisk)
26 juni 2019
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
9 november 2020
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
5 november 2020
Senast verifierad
1 november 2020
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- HM20015399
- 1-19-PDF-041-R (Annat bidrag/finansieringsnummer: American Diabetes Association)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
NEJ
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Typ 1-diabetes
-
HealthCore-NERIYale UniversityAvslutadTyp 1 diabetes | Typ 1 diabetes mellitusFörenta staterna
-
Medical College of WisconsinIndiana University; Benaroya Research InstituteRekryteringDiabetes mellitus | Diabetes mellitus, typ 1 | Typ 1 diabetes | Typ 1 diabetes mellitusFörenta staterna
-
Medical College of WisconsinAktiv, inte rekryterandeTyp 1 diabetes | Typ 1-diabetes | Typ 1-diabetes mellitusFörenta staterna
-
Eledon PharmaceuticalsIndragenSpröd typ 1-diabetes mellitusFörenta staterna
-
Medical College of WisconsinAvslutadTyp 1 diabetes | Typ 1 diabetes mellitusFörenta staterna
-
Ain Shams UniversityOkändTyp 1-diabetes mellitus med hypoglykemi | typ 1 diabetesEgypten
-
Steno Diabetes Center CopenhagenUniversity of CopenhagenAvslutadStörningar i glukosmetabolism | Typ 1 diabetes | Typ 1 diabetes mellitusDanmark
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)AvslutadTyp 1-diabetes mellitus | T1DM | T1D | Nyuppkommen typ 1-diabetes mellitusFörenta staterna, Australien
-
Capillary Biomedical, Inc.AvslutadDiabetes mellitus, typ 1 | Typ 1-diabetes | Typ 1-diabetes mellitus | Diabetes mellitus, insulinberoende, 1Australien
-
Shanghai Changzheng HospitalRekryteringSpröd typ 1-diabetes mellitusKina
Kliniska prövningar på Transition preparation intervention
-
McMaster UniversityRekryteringInflammatoriska tarmsjukdomar | Juvenil idiopatisk artritKanada
-
University of KansasAvslutadTyp 1-diabetesFörenta staterna
-
Butler HospitalNational Institute of Mental Health (NIMH); Brown UniversityAnmälan via inbjudanSchizofreni | Bipolär sjukdom | Djup depressionFörenta staterna
-
St. Jude Children's Research HospitalNational Heart, Lung, and Blood Institute (NHLBI)Rekrytering
-
Boston Medical CenterNational Institute of Mental Health (NIMH)IndragenAutismspektrumstörning
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH); Aurum InstituteAvslutadHiv | Följsamhet, tålmodigSydafrika
-
University of Southern CaliforniaThe Leona M. and Harry B. Helmsley Charitable TrustAvslutadTyp 1-diabetes mellitusFörenta staterna
-
National Taiwan University HospitalOkändFöräldraskap | Partner, Inrikes
-
Wake Forest University Health SciencesAvslutadÅterinläggning på sjukhusFörenta staterna
-
Cambridge Health AllianceAvslutadPatientutskrivningFörenta staterna